Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Variants on Inpatient Clinical Outcome

• Published in: Clinical infectious diseases Vol. 76; no. 9; pp. 1539 - 1549
• Main Authors: Robinson, Matthew L, Morris, C Paul, Betz, Joshua F, Zhang, Yifan, Bollinger, Robert, Wang, Natalie, Thiemann, David R, Fall, Amary, Eldesouki, Raghda E, Norton, Julie M, Gaston, David C, Forman, Michael, Luo, Chun Huai, Zeger, Scott L, Gupta, Amita, Garibaldi, Brian T, Mostafa, Heba H
• Format: Journal Article
• Language: English
• Published: US Oxford University Press 03.05.2023
• Subjects: COVID-19 - epidemiology; COVID-19 Vaccines; Editor's Choice; Humans; Inpatients; Major; SARS-CoV-2 - genetics; COVID-19; inpatient outcomes; Omicron variant; SARS-CoV-2; Delta variant
• ISSN: 1058-4838; 1537-6591
• DOI: 10.1093/cid/ciac957

Abstract Background Prior observation has shown differences in COVID-19 hospitalization risk between SARS-CoV-2 variants, but limited information describes hospitalization outcomes. Methods Inpatients with COVID-19 at 5 hospitals in the eastern United States were included if they had hypoxia, tachypnea, tachycardia, or fever, and SARS-CoV-2 variant data, determined from whole-genome sequencing or local surveillance inference. Analyses were stratified by history of SARS-CoV-2 vaccination or infection. The average effect of SARS-CoV-2 variant on 28-day risk of severe disease, defined by advanced respiratory support needs, or death was evaluated using models weighted on propensity scores derived from baseline clinical features. Results Severe disease or death within 28 days occurred for 977 (29%) of 3369 unvaccinated patients and 269 (22%) of 1230 patients with history of vaccination or prior SARS-CoV-2 infection. Among unvaccinated patients, the relative risk of severe disease or death for Delta variant compared with ancestral lineages was 1.30 (95% confidence interval [CI]: 1.11–1.49). Compared with Delta, the risk for Omicron patients was .72 (95% CI: .59–.88) and compared with ancestral lineages was .94 (.78–1.1). Among Omicron and Delta infections, patients with history of vaccination or prior SARS-CoV-2 infection had half the risk of severe disease or death (adjusted hazard ratio: .40; 95% CI: .30–.54), but no significant outcome difference by variant. Conclusions Although risk of severe disease or death for unvaccinated inpatients with Omicron was lower than with Delta, it was similar to ancestral lineages. Severe outcomes were less common in vaccinated inpatients, with no difference between Delta and Omicron infections. Unvaccinated adults hospitalized with COVID-19 with Delta infections had increased risk of requiring advanced respiratory support or dying within 28 days, compared with Omicron and ancestral lineages, which were similar. Vaccination lowered severe disease risk, with no Omicron versus Delta difference.